Gene Therapy for Wet AMD
NCT05611424
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Neovascular Age-related Macular Degeneration
Interventions
GENETIC:
FT-003
Sponsor
Frontera Therapeutics
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]